Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,728 announcements in the last 12 months · page 10 of 108
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Cpi Aerostructures Inc. (CVU) | Q2 FY2026 | $17.6M | 15.8% | $685,615 | 0.05 | — | 8-K |
| 2026-08-13 | Charlotte's Web Holdings, Inc. (CWBHF) | Q2 FY2026 | $10.9M | -15.2% | $-4.1M | -0.02 | — | 8-K |
| 2026-08-13 | CaliberCos Inc. (CWD) | Q2 FY2026 | $3.7M | -9.8% | $-3.4M | -0.38 | — | 8-K |
| 2026-08-13 | Dillard'S, Inc. (DDS) | Q2 FY2026 | $1.51B | -0.4% | $97.7M | 6.25 | 34.1% | 8-K |
| 2026-08-13 | Dawson Geophysical Co. (DWSN) | Q2 FY2026 | $17.9M | 81.8% | $-3.4M | -0.11 | — | 8-K |
| 2026-08-13 | Elite Pharmaceuticals Inc. (ELTP) | Q1 FY2027 | $32.4M | -19.5% | $5.9M | — | — | 8-K |
| 2026-08-13 | Elutia Inc. (ELUT) | Q2 FY2026 | $2.4M | -11.6% | $-7.6M | -0.17 | — | 8-K |
| 2026-08-13 | Equillium, Inc. (EQ) | Q2 FY2026 | — | — | $-4.7M | -0.04 | — | 8-K |
| 2026-08-13 | Eton Pharmaceuticals, Inc. (ETON) | Q2 FY2026 | $37.6M | 98.6% | $11.6M | 0.35 | — | 8-K |
| 2026-08-13 | enCore Energy Corp. (EU) | Q2 FY2026 | $15.7M | 328.4% | $-41.4M | -0.21 | — | 8-K |
| 2026-08-13 | Fate Therapeutics Inc. (FATE) | Q2 FY2026 | $2.1M | 9.2% | $-30.2M | -0.25 | — | 8-K |
| 2026-08-13 | Fortress Biotech, Inc. (FBIO) | Q2 FY2026 | $18.7M | 14.0% | $-468,000 | — | — | 8-K |
| 2026-08-13 | Falcon's Beyond Global, Inc. (FBYD) | Q2 FY2026 | $5.6M | 120.4% | $-160,000 | — | — | 8-K |
| 2026-08-13 | 4D Molecular Therapeutics, Inc. (FDMT) | Q2 FY2026 | $3.8M | 25106.7% | $-72.9M | -1.04 | — | 8-K |
| 2026-08-13reported in filing | Fennec Pharmaceuticals Inc. (FENC) | Q2 FY2026 | $17.9M | 85.2% | $2.0M | 0.05 | — | 8-K |
| 2026-08-13 | Figure Technology Solutions, Inc. (FIGR) | Q2 FY2026 | $225.6M | 112.7% | $87.4M | 0.35 | 337.5% | 8-K |
| 2026-08-13 | Firy Inc. (FIRY) | Q2 FY2026 | $31.0M | 22.9% | $-24.5M | -1.52 | — | 8-K |
| 2026-08-13 | Edap Tms SA (FOCL) | Q2 FY2026 | $13.2M | 38.8% | $-14.5M | -0.39 | — | 8-K |
| 2026-08-13reported in filing | First America Resources Corp (FSTJ) | Q2 FY2026 | $5.8M | 20.0% | $483,011 | — | — | 8-K |
| 2026-08-13 | Fitlife Brands, Inc. (FTLF) | Q2 FY2026 | $26.5M | 64.6% | $1.9M | 0.20 | 11.1% | 8-K |
| 2026-08-13 | Gemini Space Station, Inc. (GEMI) | Q2 FY2026 | $45.5M | 36.6% | $-107.7M | -0.89 | — | 8-K |
| 2026-08-13 | Genasys Inc. (GNSS) | Q3 FY2026 | $7.3M | -26.0% | $-4.7M | -0.10 | — | 8-K |
| 2026-08-13 | Gossamer Bio, Inc. (GOSS) | Q2 FY2026 | $9.2M | -19.6% | $16.9M | — | — | 8-K |
| 2026-08-13 | Global Water Resources, Inc. (GWRS) | Q2 FY2026 | $17.8M | 24.8% | $2.7M | 0.10 | 66.7% | 8-K |
| 2026-08-13reported in filing | Healthcare Triangle, Inc. (HCTI) | Q2 FY2026 | $9.2M | 158.4% | $-4.4M | -1.56 | — | 8-K |
| 2026-08-13reported in filing | Heritage Global Inc. (HGBL) | Q2 FY2026 | $12.3M | -14.3% | $-15.9M | -0.46 | -1020.0% | 8-K |
| 2026-08-13 | Health In Tech, Inc. (HIT) | Q2 FY2026 | $8.1M | -13.5% | $-2.5M | -0.04 | -500.0% | 8-K |
| 2026-08-13 | Horizon Kinetics Holding Corp (HKHC) | Q2 FY2026 | $19.0M | 0.7% | $-18.4M | -0.99 | — | 8-K |
| 2026-08-13 | HeartCore Enterprises, Inc. (HTCR) | Q2 FY2026 | $321,428 | -93.2% | $-2.0M | — | — | 8-K |
| 2026-08-13 | Heartflow, Inc. (HTFL) | Q2 FY2026 | $64.1M | 47.6% | $-15.7M | -0.18 | — | 8-K |
| 2026-08-13 | Innovative Solutions & Support Inc. (IA) | Q3 FY2026 | $26.7M | 10.7% | $4.5M | 0.25 | 78.6% | 8-K |
| 2026-08-13 | Immucell Corp. (ICCC) | Q2 FY2026 | $7.2M | 11.5% | $1.8M | 0.20 | 233.3% | 8-K |
| 2026-08-13 | Intellicheck, Inc. (IDN) | Q2 FY2026 | $5.9M | 16.0% | $663,000 | 0.03 | — | 8-K |
| 2026-08-13reported in filing | Idaho Strategic Resources, Inc. (IDR) | Q2 FY2026 | $10.7M | 13.2% | $3.7M | 0.23 | 15.0% | 8-K |
| 2026-08-13reported in filing | Triller Group Inc. (ILLR) | Q2 FY2026 | $5.2M | -5.2% | $-28.4M | — | — | 8-K |
| 2026-08-13reported in filing | Inflection Point Acquisition Corp. III (IPCX) | Q2 FY2026 | — | — | $1.9M | — | — | 8-K |
| 2026-08-13 | Invivyd, Inc. (IVVD) | Q2 FY2026 | $14.3M | 21.2% | $-44.4M | -0.14 | — | 8-K |
| 2026-08-13 | Jefferson Capital, Inc. (JCAP) | Q2 FY2026 | $177.5M | 16.3% | $41.3M | 0.67 | — | 8-K |
| 2026-08-13reported in filing | JFB Construction Holdings (JFB) | Q2 FY2026 | — | — | $-4.0M | -0.23 | — | 8-K |
| 2026-08-13reported in filing | KBS Real Estate Investment Trust III, Inc. (KBSR) | Q2 FY2026 | $56.0M | -14.4% | $-39.5M | -0.27 | — | 8-K |
| 2026-08-13 | KIDZ AI Inc. (KIDZ) | Q2 FY2026 | $481,831 | -33.6% | $-2.5M | — | — | 8-K |
| 2026-08-13 | KinderCare Learning Companies, Inc. (KLC) | Q2 FY2026 | $697.5M | -0.4% | $-8.8M | -0.07 | -121.2% | 8-K |
| 2026-08-13 | Karyopharm Therapeutics Inc. (KPTI) | Q2 FY2026 | $33.4M | -11.9% | $-67.0M | -2.32 | — | 8-K |
| 2026-08-13 | KULR Technology Group, Inc. (KULR) | Q2 FY2026 | $2.1M | -43.0% | $-22.0M | -0.47 | -313.6% | 8-K |
| 2026-08-13 | Kyntra Bio, Inc. (KYNB) | Q2 FY2026 | $-1.5M | -209.3% | $12.0M | 2.96 | — | 8-K |
| 2026-08-13 | Legence Corp. (LGN) | Q2 FY2026 | $1.26B | 110.7% | $-27.8M | -0.37 | — | 8-K |
| 2026-08-13 | Chicago Atlantic BDC, Inc. (LIEN) | Q2 FY2026 | — | — | $6.1M | 0.27 | -28.9% | 8-K |
| 2026-08-13 | Interlink Electronics Inc. (LINK) | Q2 FY2026 | $3.8M | 10.4% | $248,000 | 0.02 | — | 8-K |
| 2026-08-13 | LIVE VENTURES Inc (LIVE) | Q3 FY2026 | $108.9M | -3.2% | $-1.1M | -0.34 | -127.4% | 8-K |
| 2026-08-13 | LENSAR, Inc. (LNSR) | Q2 FY2026 | $14.7M | 19.8% | $3.5M | — | — | 8-K |
| 2026-08-13 | ContextLogic Holdings Inc. (LOGC) | Q2 FY2026 | $33.6M | -0.6% | $-6.3M | -0.14 | — | 8-K |
| 2026-08-13 | Laird Superfood, Inc. (LSF) | Q2 FY2026 | $41.3M | 244.4% | $-1.8M | -0.25 | — | 8-K |
| 2026-08-13 | Intuitive Machines, Inc. (LUNR) | Q2 FY2026 | $203.4M | 304.3% | $-46.4M | -0.29 | — | 8-K |
| 2026-08-13 | Lifeway Foods, Inc. (LWAY) | Q2 FY2026 | $66.9M | 24.1% | $127,000 | 0.01 | -96.4% | 8-K |
| 2026-08-13reported in filing | Medalist Diversified, Inc. (MDRR) | Q2 FY2026 | $1.8M | -26.6% | $-418,684 | -0.26 | — | 8-K |
| 2026-08-13 | Macrogenics Inc. (MGNX) | Q2 FY2026 | $32.8M | 378.0% | $19.5M | 0.31 | — | 8-K |
| 2026-08-13reported in filing | Marblegate Capital Corp (MGTE) | Q2 FY2026 | $16.7M | -6.1% | $-4.3M | -0.06 | — | 8-K |
| 2026-08-13 | MeiraGTx Holdings plc (MGTX) | Q2 FY2026 | $321.4M | 8608.6% | $160.7M | 1.71 | — | 8-K |
| 2026-08-13 | McGraw Hill, Inc. (MH) | Q1 FY2027 | $549.9M | 2.6% | $57.9M | 0.30 | — | 8-K |
| 2026-08-13 | Madison Square Garden Sports Corp. (MSGS) | Q4 FY2026 | $278.7M | 36.7% | $28.3M | 1.15 | — | 8-K |
| 2026-08-13 | Nektar Therapeutics (NKTR) | Q2 FY2026 | $10.1M | -9.3% | $-40.6M | -1.23 | — | 8-K |
| 2026-08-13 | Newsmax Inc. (NMAX) | Q2 FY2026 | $54.1M | 16.5% | $2.9M | 0.02 | — | 8-K |
| 2026-08-13 | NextPlat Corp (NXPL) | Q2 FY2026 | $11.9M | -10.3% | $-144,000 | — | — | 8-K |
| 2026-08-13 | Nextnrg, Inc. (NXXT) | Q2 FY2026 | $27.7M | 40.9% | $-6.6M | -0.04 | — | 8-K |
| 2026-08-13 | Ondas Inc. (ONDS) | Q2 FY2026 | $83.8M | 1235.4% | $-88.4M | -0.19 | — | 8-K |
| 2026-08-13 | Pedevco Corp. (PED) | Q2 FY2026 | $46.1M | 561.4% | $17.5M | 1.31 | — | 8-K |
| 2026-08-13 | Petmed Express Inc. (PETS) | Q1 FY2027 | $41.0M | -19.9% | $-6.1M | -0.28 | — | 8-K |
| 2026-08-13 | GrabAGun Digital Holdings Inc. (PEW) | Q2 FY2026 | $23.2M | 9.4% | $-1.8M | -0.06 | — | 8-K |
| 2026-08-13reported in filing | PGIM Private Credit Fund (PGIM) | Q2 FY2026 | — | — | $6.4M | — | — | 8-K |
| 2026-08-13 | Pelthos Therapeutics Inc. (PTHS) | Q2 FY2026 | $15.6M | — | $-23.4M | -6.62 | — | 8-K |
| 2026-08-13 | Pyxis Oncology, Inc. (PYXS) | Q2 FY2026 | — | — | $-25.3M | -0.40 | — | 8-K |
| 2026-08-13reported in filing | Quantum X Labs Inc. (QXL) | Q2 FY2026 | $293,000 | -87.2% | $2.5M | — | — | 8-K |
| 2026-08-13 | QXO, Inc. (QXO) | Q2 FY2026 | $3.25B | 70.3% | $-55.0M | -0.14 | — | 8-K |
| 2026-08-13 | Roadzen Inc. (RDZN) | Q1 FY2027 | $16.2M | 49.0% | $-9.8M | -0.12 | — | 8-K |
| 2026-08-13 | Rekor Systems, Inc. (REKR) | Q2 FY2026 | $12.7M | 2.5% | $-551,000 | — | — | 8-K |
| 2026-08-13 | Rockwell Medical, Inc. (RMTI) | Q2 FY2026 | $17.8M | 10.6% | $-1.2M | — | — | 8-K |
| 2026-08-13 | SBC Medical Group Holdings Inc (SBC) | Q2 FY2026 | $49.2M | 13.4% | $10.7M | 0.10 | 400.0% | 8-K |
| 2026-08-13 | Solo Brands, Inc. (SBDS) | Q2 FY2026 | $88.5M | -4.1% | $-4.4M | -1.72 | — | 8-K |
| 2026-08-13 | Saga Communications Inc. (SGA) | Q2 FY2026 | $26.4M | -6.5% | $960,000 | 0.15 | -16.7% | 8-K |
| 2026-08-13 | SPAR Group, Inc. (SGRP) | Q2 FY2026 | $36.9M | -4.5% | $409,000 | 0.02 | — | 8-K |
| 2026-08-13 | Soluna Holdings, Inc (SLNH) | Q2 FY2026 | $15.1M | 144.6% | $-20.7M | -0.18 | — | 8-K |
| 2026-08-13 | Smith Micro Software, Inc. (SMSI) | Q2 FY2026 | $4.3M | -1.8% | $-2.6M | — | — | 8-K |
| 2026-08-13 | Spruce Power Holding Corp. (SPRU) | Q2 FY2026 | $30.3M | -8.7% | $3.3M | 0.15 | — | 8-K |
| 2026-08-13 | ARS Pharmaceuticals, Inc. (SPRY) | Q2 FY2026 | $33.7M | 114.2% | $-62.3M | -0.63 | — | 8-K |
| 2026-08-13 | Sensus Healthcare, Inc. (SRTS) | Q2 FY2026 | $2.3M | -68.7% | $-8.7M | -0.53 | — | 8-K |
| 2026-08-13 | SS Innovations International, Inc. (SSII) | Q2 FY2026 | $13.9M | 39.4% | $-2.7M | -0.01 | — | 8-K |
| 2026-08-13 | Techprecision Corp. (TPCS) | Q1 FY2027 | $9.1M | 23.3% | $-153,000 | -0.02 | — | 8-K |
| 2026-08-13 | Tapestry, Inc. (TPR) | Q4 FY2026 | $1.88B | 8.9% | $347.8M | 1.68 | — | 8-K |
| 2026-08-13 | TSS, Inc. (TSSI) | Q2 FY2026 | $34.9M | -20.7% | $1.4M | 0.05 | -16.7% | 8-K |
| 2026-08-13 | Venu Holding Corp (VENU) | Q2 FY2026 | $4.8M | 6.9% | $-17.9M | -0.30 | — | 8-K |
| 2026-08-13 | Veritone, Inc. (VERI) | Q2 FY2026 | $24.3M | 4.6% | $-22.2M | -0.24 | — | 8-K |
| 2026-08-13 | Workhorse Group Inc. (WKHS) | Q2 FY2026 | $3.6M | 374.9% | $-20.2M | -1.86 | — | 8-K |
| 2026-08-13 | Wolverine World Wide Inc. (WWW) | Q2 FY2025 | $506.4M | 6.8% | $31.2M | 0.37 | 15.6% | 8-K |
| 2026-08-13 | XBP Global Holdings, Inc. (XBP) | Q4 FY2025 | $191.3M | -8.3% | $-16.7M | — | — | 8-K |
| 2026-08-13reported in filing | XCel Brands, Inc. (XELB) | Q2 FY2026 | $1.1M | -15.1% | $-2.5M | -0.40 | — | 8-K |
| 2026-08-13 | Xos, Inc. (XOS) | Q2 FY2026 | $4.7M | -74.2% | $-6.9M | -0.55 | — | 8-K |
| 2026-08-13 | 22nd Century Group, Inc. (XXII) | Q2 FY2026 | $2.9M | -29.9% | $-3.3M | — | — | 8-K |
| 2026-08-13 | YETI Holdings, Inc. (YETI) | Q2 FY2026 | $483.9M | 8.5% | $71.3M | 0.94 | 54.1% | 8-K |
| 2026-08-13 | Zenas BioPharma, Inc. (ZBIO) | Q2 FY2026 | $1.0M | — | $-111.5M | -1.77 | — | 8-K |
| 2026-08-13 | zSpace, Inc. (ZSPC) | Q2 FY2026 | $5.4M | -27.7% | $288,000 | 0.01 | — | 8-K |
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.